No Data
No Data
Express News | Palmer Square Capital BDC Inc : UBS Cuts Target Price to $16.5 From $17
Analysts Offer Insights on NA Companies: CG Oncology, Inc. (CGON), Smith Douglas Homes Corp. Class A (SDHC) and Palmer Square Capital BDC Inc. (PSBD)
BofA Securities Maintains Palmer Square Capital BDC(PSBD.US) With Hold Rating, Maintains Target Price $16.5
Neutral Outlook on Palmer Square Capital BDC Amid Balanced Risk and Strategic Positioning
Oppenheimer Maintains Palmer Square Capital BDC(PSBD.US) With Buy Rating, Maintains Target Price $17
J.P. Morgan Maintains Palmer Square Capital BDC(PSBD.US) With Buy Rating, Cuts Target Price to $16.5
No Data
No Data